THIS IS A SOURCES SOUGHT NOTICE BEING RELEASED PURSUANT TO FEDERAL ACQUISITION REGULATION (FAR) PART 10: MARKET RESEARCH. This Sources Sought Notice is issued solely for informational, market research, and planning purposes only. It does not constitute a Request for Quotes (RFQ) or a promise to issue an RFQ in the future. This Sources Sought Notice does not commit the Government to contract for any supply or service whatsoever. Further, the U.S. Department of Veterans Affairs, Network Contracting Office (NCO) 15, Consolidated Mail Outpatient Pharmacy (CMOP) Acquisitions is not seeking quotes, and will not accept unsolicited quotes. Respondents are advised that the United States (U.S) Government will not pay for any information or administrative cost incurred in response to this Sources Sought Notice. All costs associated with responding to this Sources Sought Notice will be solely at the responding party s expense. Responses to the Source Sought Notice will not be returned. Please be advised that all submissions become Government property and will not be returned. Responses to this notice are not offers and cannot be accepted by the U.S Government to form a binding contract. It is the responsibility of the interested parties to monitor the Federal Business Opportunities (www.fbo.gov) site for additional information pertaining to this Sources Sought Notice. The Government does not intend to award a contract from this Sources Sought Notice or to otherwise pay for the information solicited. Your respective company s response will be treated as information only and shall not be used as a proposal. NAICS Code is 325412 (Pharmaceuticals Preparation Manufacturing) and Product Service Code (PSC) is 6505 (Drugs and Biologicals). Small Business Size Standard is 1,250 employees. Objective: The objective of this RFI is to conduct market research to specifically seek small business manufacturers only (not resellers, authorized dealers, or large business manufacturers) capable of providing any of the following specific strength pharmaceuticals requested by the National Consolidated Mail Outpatient Pharmacy (CMOP) at the Department of Veterans Affairs: Item Number CMOP ID Description 1 A0321 ANTIPYRINE 5.4/BENZOCAINE 1.4% OTIC SOLN 2 A0725 ALBUTEROL SO4 0.083% INHL 3ML 3 A0740 ATORVASTATIN CALCIUM 40MG TAB 4 A0766 ANAGRELIDE HCL (0.5MG CAP) 5 A1126 ATORVASTATIN CALCIUM 80MG TAB 6 A1222 ACAMPROSATE CA 333MG EC TAB 7 A1354 ALUMINUM SULFATE/CALCIUM ACETAT TOP PWDR 8 B0014 BACLOFEN 10MG TAB 9 B0015 BACLOFEN 20MG TAB 10 B0098 BENZONATATE 100MG CAP 11 B0185 BISACODYL (10MG ENEMA) 12 B0190 BUMETANIDE (0.5 MG TAB) 13 B0191 BUMETANIDE (1MG TAB) 14 B0192 BUMETANIDE (2MG TAB) 15 B0565 BENZONATATE 100MG CAP 16 B0585 BUPROPION HCL 50MG 24HR SA TAB 500CT 17 B0595 BACITRACIN (500/POLYMYXIN 10000/GM OINT) 18 B0808 BUDESONIDE 32 MCG 120D NASAL INHL 19 C1517 CALCIUM 119MG/MAGNESIUM 71.5MG EC TAB 60CT 20 C1658 CARBAMAZEPINE (SHIRE) 300MG CAP,SA 21 C1761 CAPSAICIN 0.1% CREAM 60GM  22 E0660 ESOMEPRAZOLE (20MG 22.3MG W/MAG EC CAP) 23 F0049 FLUOXETINE HCL 20MG CAP, 1000CT 24 G0028 GLYCOPYRROLATE (1MG TAB) 25 G0174 GLUCOSE 4GM CHEW TAB 50CT 26 H0052 HYDROCORTISONE (0.5% CREAM) 27 H0055 HYDROCORTISONE 1% CREAM 454GM JAR 28 H0055 HYDROCORTISONE 1% CREAM 30GM JAR/tube 29 H0062 HYDROCORTISONE 2.5% OINT 20GM 30 H0086 HYDROXYZINE PAMOATE (100MG CAP) 31 H0442 HYPROMELLOSE (0.3% OPH GEL) 32 H0469 HYDROCORTISONE 1%/PRAMOXINE 1% TOP OINT 30GM 33 H0481 HYDROCORTIZONE 12.5MG/LOSARTAN 100MG TAB 34 H0494 HYDROCORTIZONE 25MG/LOSARTAN (100MG TAB) 35 L0044 LISINOPRIL 20MG TAB 36 L0045 LISINOPRIL 40MG TAB 37 L0046 LISINOPRIL 5MG TAB 38 L0051 LITHIUM CARBONATE 450MG SA TAB 100CT 39 L0131 LISINOPRIL 2.5MG TAB 40 L0152 LEVORA TAB, 28 41 N0245 NEFAZODONE 200MG TAB 60CT 42 P0351 POTASSIUM CHLORIDE (20MEQ / 15ML (SF) LIQ) 43 P0572 PANTOPRAZOLE NA 40MG EC TAB 44 P0692 PANTOPRAZOLE NA 20MG EC TAB 45 P1082 PHENAZOPYRIDINE (HCL 97.5MG TAB) 46 R0002 RAMIPRIL 10MG CAP 100CT 47 R0065 ROPINIROLE HCL 0.25MG TAB 48 R0066 ROPINIROLE HCL 0.5MG TAB 49 R0067 ROPINIROLE HCL 1MG TAB 50 R0068 ROPINIROLE HCL 2MG TAB 51 R0069 ROPINIROLE HCL 5MG TAB 52 R0126 ROPINIROLE HCL 4MG TAB 53 R0144 ROPINIROLE HCL 3MG TAB 54 S0002 ARTIFICIAL SALIVA 240ML 55 S0004 SALSALATE (750MG TAB) 56 S0167 SODIUM CHLORIDE (2% OPH SOLN) 57 S0195 SUMATRIPTAN SUCCINATE 25MG TAB 58 S0196 SUMATRIPTAN SUCCINATE 50MG TAB 59 S0411 SALICYLIC ACID (17% SOLN TOP) 60 T0018 THEOPHYLLINE 100MG SA TAB 61 T0020 THEOPHYLLINE 200MG SA TAB 62 T0385 TAMSULOSIN HCL 0.4MG CAP 63 V0181 VENLAFAXINE HCL 37.5MG 24HR SA TAB 64 Z0020 ZOLPIDEM TARTRATE 10MG TAB 65 Z0036 ZOLPIDEM TARTRATE 5MG TAB Instructions for Sources Sought Notice Responses: Responses must be submitted electronically to the Contract Specialist, Doug Reed, at [email protected] with cc to Linda Bayer, Contracting Officer, at [email protected]. Please list Sources Sought Response - Pharmaceuticals in subject line of e-mail. Responses are due by 10:00am Central Standard Time (CST), 9-13-2017. No phone calls please. Respondents must submit their responses via email in .pdf format. The response should be no more than 10 pages in length (inclusive of charts, graphs, screenshots, and pictures), no larger than 9 megabytes for PDF, and should use font size 11 or larger. Proprietary information submitted in response to this Sources Sought Notice will be protected from unauthorized disclosure as required by the Federal Acquisition Regulation (FAR). All proprietary markings should be clearly delineated. The respondent shall identify where data is restricted by proprietary or other rights and mark it accordingly. The format for the Sources Sought Notice responses is described below: Cover Page: Shall contain (1) Company name, (2) Primary and Alternate Points of Contact, (3) Phone Numbers and Email Addresses, (4) DUNS Number, (5) Primary NAICS Code/Federal Supply Code (FSC), and (6) Type of Small Business Size (i.e. Small Business, Service Disabled Veteran Owned Small Business, Veteran Owned Small Business, Woman Owned Small Business, Small Disadvantaged Business, HUBZone Business, or 8(a) Small Business. Resource Capabilities: Provide a brief description of existing capability to provide the specific strength pharmaceuticals stated above. Also, validate this capability by providing verification such as product literature, price list, etc. Please do not provide generic capability statements as they will add no value to this Sources Sought Notice. The Government is seeking specific information in conjunction with the requirements stated above and in the draft SOW. Clarification of RFI Responses: To fully comprehend the information contained within a response to this Sources Sought Notice, there may be a need by the Contracting Officer to seek further clarification from those small business manufacturers who submitted responses.

Bid Protests Not Available